Skip to main content

Table 3 Summary data from Oral Ketamine Trial on Suicidality (OKTOS) used in BN for predicting therapeutic response to oral ketamine (n = 32 at pre-treatment assessment phase)

From: Predicting therapeutic response to oral ketamine for chronic suicidal ideation: a Bayesian network for clinical decision support

Variable

n

%

Age

 <25 years

2

6

 25–44 years

13

41

 45–64 years

15

47

 ≥ 65 years

2

6

Female

16

50

Tertiary education

19

59

Employed

10

31

Partnered

13

41

Suicide attempts

 none

7

22

 one

9

28

 two or more

16

50

BMI

 healthy

11

34

 overweight

7

22

 obese

14

44

MADRS

 not severe

4

13

 severe

28

87

SOFAS

 low

11

34

 high

21

66

Prolonged response

 yes

15

50a

 no

15

50a

  1. an = 30 at follow-up phase